Brad Hartman is a purpose-driven biotech executive and entrepreneur who is deeply committed to unlocking the potential in individuals, teams and the company to radically improve patients' lives. He passionately believes in the power of culture to elevate organizational performance and capability through innovative People practices and a more humanistic, caring approach.
Brad has spent the past 15 years building teams and culture at biotech companies from early research stages through commercialization. He has deep cell and gene therapy experience from Unum Therapeutics (CAR-T) as well as FerGene (gene therapy), where he recently served as the chief people officer. Brad has played a significant role in launching multiple innovative therapies, including Kalydeco® (cystic fibrosis), Kalbitor® (hereditary angioedema) and Incivek® (hepatitis C), which was one of the fastest blockbuster drug launches of all time. Brad also founded and built out his own Executive Search firm, ConnectedSearch, into a leading life science search practice.
Brad received his B.S. in neuroscience from the University of Rochester and worked at both the National Cancer Institute and the Graduate School of Pharmacology at the University of Rochester in cellular pharmacology.
